LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 25

Search options

  1. Book ; Online: Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection

    Marklund, Emelie / Leach, Susannah / Gisslén, Magnus

    2020  

    Abstract: SARS-CoV-2 specific serum IgG (AU/ml), as measured by iFlash 1800 chemiluminescent immunoassay (YHLO, China), in 15 patients with severe COVID-19 and 32 patients with mild COVID-19 over >90 days follow-up post symptom onset. SARS-CoV-2 receptor binding ... ...

    Abstract SARS-CoV-2 specific serum IgG (AU/ml), as measured by iFlash 1800 chemiluminescent immunoassay (YHLO, China), in 15 patients with severe COVID-19 and 32 patients with mild COVID-19 over >90 days follow-up post symptom onset. SARS-CoV-2 receptor binding domain specific serum IgM, IgG and IgA in samples collected >75 days post symtom onset from 21 patients with mild or severe COVID-19. Measured by in-house ELISA, results presented as AUC of titration curve.
    Keywords covid19
    Publishing date 2020-07-07
    Publishing country eu
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Book ; Online: Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection

    Marklund, Emelie / Leach, Susannah / Gisslén, Magnus

    2020  

    Abstract: SARS-CoV-2 specific serum IgG (AU/ml), as measured by iFlash 1800 chemiluminescent immunoassay (YHLO, China), in 15 patients with severe COVID-19 and 32 patients with mild COVID-19 over >90 days follow-up post symptom onset. SARS-CoV-2 receptor binding ... ...

    Abstract SARS-CoV-2 specific serum IgG (AU/ml), as measured by iFlash 1800 chemiluminescent immunoassay (YHLO, China), in 15 patients with severe COVID-19 and 32 patients with mild COVID-19 over >90 days follow-up post symptom onset. SARS-CoV-2 receptor binding domain specific serum IgM, IgG and IgA in samples collected >75 days post symtom onset from 21 patients with mild or severe COVID-19. Measured by in-house ELISA, results presented as AUC of titration curve.
    Keywords covid19
    Publishing date 2020-07-07
    Publishing country eu
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses.

    Lundgren, Anna / Leach, Susannah / Axelsson, Hannes / Isakson, Pauline / Nyström, Kristina / Scharf, Lydia / Andersson, Bengt A / Miron, Nicolae / Marklund, Emelie / Andersson, Lars-Magnus / Gisslén, Magnus / Angeletti, Davide / Bemark, Mats

    Clinical and experimental immunology

    2023  Volume 213, Issue 2, Page(s) 173–189

    Abstract: Antigen-specific class-switched antibodies are detected at the same time or even before IgM in serum of non-vaccinated individuals infected with SARS-CoV-2. These derive from the first wave of plasmablasts formed. Hence, the phenotype and specificity of ... ...

    Abstract Antigen-specific class-switched antibodies are detected at the same time or even before IgM in serum of non-vaccinated individuals infected with SARS-CoV-2. These derive from the first wave of plasmablasts formed. Hence, the phenotype and specificity of plasmablasts can reveal information about early B-cell activation. Here we have analyzed B cells and plasmablasts circulating in blood of COVID-19 patients not previously exposed to SARS-CoV-2 during and after disease. We find that during infection with the original Wuhan strain, plasmablasts in blood produce IgA1, IgG1, and IgM, and that most express CCR10 and integrin β1, only some integrin β7, while the majority lack CCR9. Plasmablast-secreted antibodies are reactive to the spike (S) and nucleocapsid (N) proteins of the Wuhan strain as well as later variants of concern, but also bind S proteins from endemic and non-circulating betacoronaviruses. In contrast, after recovery, antibodies produced from memory B cells target variants of SARS-CoV-2 and SARS-CoV-1 but compared to previously non-infected individuals do not show increased binding to endemic coronaviruses. This suggests that the early antibody response to a large extent stems from pre-existing cross-reactive class-switched memory B cells, and that although newly formed memory cells target the novel SARS-CoV-2 virus the numbers of broadly cross-reactive memory B cells do not increase extensively. The observations give insight into the role of pre-existing memory B cells in early antibody responses to novel pathogens and may explain why class-switched antibodies are detected early in the serum of COVID-19 patients.
    MeSH term(s) Humans ; SARS-CoV-2 ; COVID-19 ; Immunoglobulin G ; Immunoglobulin M ; Antibodies, Viral ; Antibodies, Neutralizing
    Chemical Substances Immunoglobulin G ; Immunoglobulin M ; Antibodies, Viral ; Antibodies, Neutralizing
    Language English
    Publishing date 2023-04-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218531-3
    ISSN 1365-2249 ; 0009-9104 ; 0964-2536
    ISSN (online) 1365-2249
    ISSN 0009-9104 ; 0964-2536
    DOI 10.1093/cei/uxad044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clones.

    Scharf, Lydia / Axelsson, Hannes / Emmanouilidi, Aikaterini / Mathew, Nimitha R / Sheward, Daniel J / Leach, Susannah / Isakson, Pauline / Smirnov, Ilya V / Marklund, Emelie / Miron, Nicolae / Andersson, Lars-Magnus / Gisslén, Magnus / Murrell, Ben / Lundgren, Anna / Bemark, Mats / Angeletti, Davide

    JCI insight

    2023  Volume 8, Issue 1

    Abstract: Understanding persistence and evolution of B cell clones after COVID-19 infection and vaccination is crucial for predicting responses against emerging viral variants and optimizing vaccines. Here, we collected longitudinal samples from patients with ... ...

    Abstract Understanding persistence and evolution of B cell clones after COVID-19 infection and vaccination is crucial for predicting responses against emerging viral variants and optimizing vaccines. Here, we collected longitudinal samples from patients with severe COVID-19 every third to seventh day during hospitalization and every third month after recovery. We profiled their antigen-specific immune cell dynamics by combining single-cell RNA-Seq, Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-Seq), and B cell receptor-Seq (BCR-Seq) with oligo-tagged antigen baits. While the proportion of Spike receptor binding domain-specific memory B cells (MBC) increased from 3 months after infection, the other Spike- and Nucleocapsid-specific B cells remained constant. All patients showed ongoing class switching and sustained affinity maturation of antigen-specific cells, and affinity maturation was not significantly increased early after vaccine. B cell analysis revealed a polyclonal response with limited clonal expansion; nevertheless, some clones detected during hospitalization, as plasmablasts, persisted for up to 1 year, as MBC. Monoclonal antibodies derived from persistent B cell families increased their binding and neutralization breadth and started recognizing viral variants by 3 months after infection. Overall, our findings provide important insights into the clonal evolution and dynamics of antigen-specific B cell responses in longitudinally sampled patients infected with COVID-19.
    MeSH term(s) Humans ; SARS-CoV-2 ; COVID-19 ; B-Lymphocytes ; Plasma Cells ; Clone Cells
    Language English
    Publishing date 2023-01-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.165299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Correction: Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.

    Marklund, Emelie / Leach, Susannah / Axelsson, Hannes / Nyström, Kristina / Norder, Heléne / Bemark, Mats / Angeletti, Davide / Lundgren, Anna / Nilsson, Staffan / Andersson, Lars-Magnus / Yilmaz, Aylin / Lindh, Magnus / Liljeqvist, Jan-Åke / Gisslén, Magnus

    PloS one

    2021  Volume 16, Issue 10, Page(s) e0258401

    Abstract: This corrects the article DOI: 10.1371/journal.pone.0241104.]. ...

    Abstract [This corrects the article DOI: 10.1371/journal.pone.0241104.].
    Language English
    Publishing date 2021-10-04
    Publishing country United States
    Document type Published Erratum
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0258401
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.

    Marklund, Maja / Schultz, Niklas / Friedrich, Stefanie / Berglund, Emelie / Tarish, Firas / Tanoglidi, Anna / Liu, Yao / Bergenstråhle, Ludvig / Erickson, Andrew / Helleday, Thomas / Lamb, Alastair D / Sonnhammer, Erik / Lundeberg, Joakim

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 5475

    Abstract: The molecular mechanisms underlying lethal castration-resistant prostate cancer remain poorly understood, with intratumoral heterogeneity a likely contributing factor. To examine the temporal aspects of resistance, we analyze tumor heterogeneity in ... ...

    Abstract The molecular mechanisms underlying lethal castration-resistant prostate cancer remain poorly understood, with intratumoral heterogeneity a likely contributing factor. To examine the temporal aspects of resistance, we analyze tumor heterogeneity in needle biopsies collected before and after treatment with androgen deprivation therapy. By doing so, we are able to couple clinical responsiveness and morphological information such as Gleason score to transcriptome-wide data. Our data-driven analysis of transcriptomes identifies several distinct intratumoral cell populations, characterized by their unique gene expression profiles. Certain cell populations present before treatment exhibit gene expression profiles that match those of resistant tumor cell clusters, present after treatment. We confirm that these clusters are resistant by the localization of active androgen receptors to the nuclei in cancer cells post-treatment. Our data also demonstrates that most stromal cells adjacent to resistant clusters do not express the androgen receptor, and we identify differentially expressed genes for these cells. Altogether, this study shows the potential to increase the power in predicting resistant tumors.
    MeSH term(s) Androgen Antagonists/pharmacology ; Androgen Antagonists/therapeutic use ; Androgens/metabolism ; Clone Cells/metabolism ; Humans ; Male ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Spatio-Temporal Analysis
    Chemical Substances Androgen Antagonists ; Androgens ; Receptors, Androgen
    Language English
    Publishing date 2022-09-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-33069-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: No effect of remdesivir or betamethasone on upper respiratory tract SARS-CoV-2 RNA kinetics in hospitalised COVID-19 patients: a retrospective observational study.

    Sourander, Birger / Andersson, Lars-Magnus / Brink, Magnus / Yilmaz, Aylin / Sundell, Nicklas / Marklund, Emelie / Nilsson, Staffan / Lindh, Magnus / Robertson, Josefina / Gisslén, Magnus

    Infectious diseases (London, England)

    2022  Volume 54, Issue 10, Page(s) 703–712

    Abstract: Background: The viral kinetics of SARS-CoV-2 has been considered clinically important. While remdesivir and corticosteroids are recommended for COVID-19 patients requiring oxygen support, there is a limited number of published reports on viral kinetics ... ...

    Abstract Background: The viral kinetics of SARS-CoV-2 has been considered clinically important. While remdesivir and corticosteroids are recommended for COVID-19 patients requiring oxygen support, there is a limited number of published reports on viral kinetics in hospitalised patients with COVID-19 treated with remdesivir or corticosteroids.
    Methods: We conducted a retrospective study by collecting longitudinal samples from the nasopharynx/throat of 123 hospitalised patients (median age 55 years, 74% male) with COVID-19, to evaluate the effects of remdesivir and corticosteroid treatment on viral RNA levels. The subjects were divided into four groups: those receiving remdesivir (
    Results: We found no significant difference in SARS-CoV-2 RNA decline rate or time to SARS-CoV-2 RNA clearance between the groups. Moreover, clinical status at baseline was not correlated with time to viral clearance.
    Conclusions: Since SARS-CoV-2 RNA kinetics was not affected by treatment, repeated sampling from the upper respiratory tract cannot be used to evaluate treatment response.
    MeSH term(s) Adenosine Monophosphate/analogs & derivatives ; Alanine/analogs & derivatives ; Antiviral Agents/therapeutic use ; Betamethasone/therapeutic use ; COVID-19/drug therapy ; Female ; Humans ; Male ; Middle Aged ; Nasopharynx ; RNA, Viral ; Retrospective Studies ; SARS-CoV-2
    Chemical Substances Antiviral Agents ; RNA, Viral ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; Betamethasone (9842X06Q6M) ; Alanine (OF5P57N2ZX)
    Language English
    Publishing date 2022-06-16
    Publishing country England
    Document type Journal Article ; Observational Study
    ZDB-ID 2839775-7
    ISSN 2374-4243 ; 2374-4235
    ISSN (online) 2374-4243
    ISSN 2374-4235
    DOI 10.1080/23744235.2022.2081716
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specific clones

    Lydia Scharf / Hannes Axelsson / Aikaterini Emmanouilidi / Nimitha R. Mathew / Daniel J. Sheward / Susannah Leach / Pauline Isakson / Ilya V. Smirnov / Emelie Marklund / Nicolae Miron / Lars-Magnus Andersson / Magnus Gisslén / Ben Murrell / Anna Lundgren / Mats Bemark / Davide Angeletti

    JCI Insight, Vol 8, Iss

    2023  Volume 1

    Abstract: Understanding persistence and evolution of B cell clones after COVID-19 infection and vaccination is crucial for predicting responses against emerging viral variants and optimizing vaccines. Here, we collected longitudinal samples from patients with ... ...

    Abstract Understanding persistence and evolution of B cell clones after COVID-19 infection and vaccination is crucial for predicting responses against emerging viral variants and optimizing vaccines. Here, we collected longitudinal samples from patients with severe COVID-19 every third to seventh day during hospitalization and every third month after recovery. We profiled their antigen-specific immune cell dynamics by combining single-cell RNA-Seq, Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-Seq), and B cell receptor–Seq (BCR-Seq) with oligo-tagged antigen baits. While the proportion of Spike receptor binding domain–specific memory B cells (MBC) increased from 3 months after infection, the other Spike- and Nucleocapsid-specific B cells remained constant. All patients showed ongoing class switching and sustained affinity maturation of antigen-specific cells, and affinity maturation was not significantly increased early after vaccine. B cell analysis revealed a polyclonal response with limited clonal expansion; nevertheless, some clones detected during hospitalization, as plasmablasts, persisted for up to 1 year, as MBC. Monoclonal antibodies derived from persistent B cell families increased their binding and neutralization breadth and started recognizing viral variants by 3 months after infection. Overall, our findings provide important insights into the clonal evolution and dynamics of antigen-specific B cell responses in longitudinally sampled patients infected with COVID-19.
    Keywords COVID-19 ; Immunology ; Medicine ; R
    Subject code 570
    Language English
    Publishing date 2023-01-01T00:00:00Z
    Publisher American Society for Clinical investigation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019.

    Yilmaz, Aylin / Marklund, Emelie / Andersson, Maria / Nilsson, Staffan / Andersson, Lars-Magnus / Lindh, Magnus / Gisslén, Magnus

    The Journal of infectious diseases

    2020  Volume 223, Issue 1, Page(s) 15–18

    Abstract: This study reports longitudinal viral RNA loads from the nasopharynx/throat in patients with mild and severe/critical coronavirus disease 2019 (COVID-19). We also investigated whether the duration of symptoms correlated with the duration of viral RNA ... ...

    Abstract This study reports longitudinal viral RNA loads from the nasopharynx/throat in patients with mild and severe/critical coronavirus disease 2019 (COVID-19). We also investigated whether the duration of symptoms correlated with the duration of viral RNA shedding. A total of 56 patients were included. The highest viral loads occurred early after onset of symptoms. Neither the viral RNA loads in the upper respiratory tract nor the time to viral RNA clearance differed between patients with mild or severe/critical disease. There was a moderate correlation between number of days with symptoms and number of days with viral RNA shedding in patients with mild COVID-19.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; COVID-19/diagnosis ; Female ; Humans ; Male ; Middle Aged ; Nasopharynx/virology ; Pharynx/virology ; RNA, Viral/analysis ; Sweden ; Viral Load ; Virus Shedding ; Young Adult
    Chemical Substances RNA, Viral
    Keywords covid19
    Language English
    Publishing date 2020-10-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiaa632
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4

    Marklund, Emelie / Leach, Susannah / Nyström, Kristina / Lundgren, Anna / Liljeqvist, Jan-Åke / Nilsson, Staffan / Yilmaz, Aylin / Andersson, Lars-Magnus / Bemark, Mats / Gisslén, Magnus

    Frontiers in immunology

    2021  Volume 12, Page(s) 750448

    Abstract: Background: The risk of SARS-CoV-2 infection among health care workers (HCWs) is a concern, but studies that conclusively determine whether HCWs are over-represented remain limited. Furthermore, methods used to confirm past infection vary and the ... ...

    Abstract Background: The risk of SARS-CoV-2 infection among health care workers (HCWs) is a concern, but studies that conclusively determine whether HCWs are over-represented remain limited. Furthermore, methods used to confirm past infection vary and the immunological response after mild COVID-19 is still not well defined.
    Method: 314 HCWs were recruited from a Swedish Infectious Diseases clinic caring for COVID-19 patients. IgG antibodies were measured using two commercial assays (Abbot Architect nucleocapsid (N)-assay and YHLO iFlash-1800 N and spike (S)-assays) at five time-points, from March 2020 to January 2021, covering two pandemic waves. Seroprevalence was assessed in matched blood donors at three time-points. More extensive analyses were performed in 190 HCWs in September/October 2020, including two additional IgG-assays (DiaSorin LiaisonXL S1/S2 and Abbot Architect receptor-binding domain (RBD)-assays), neutralizing antibodies (NAbs), and CD4
    Findings: Seroprevalence was higher among HCWs compared to sex and age-matched blood donors at all time-points. Seropositivity increased from 6.4% to 16.3% among HCWs between May 2020 and January 2021, compared to 3.6% to 11.9% among blood donors. We found significant correlations and high levels of agreement between NAbs and all four commercial IgG-assays. At 200-300 days post PCR-verified infection, there was a wide variation in sensitivity between the commercial IgG-assays, ranging from <30% in the N-assay to >90% in the RBD-assay. There was only moderate agreement between NAbs and CD4
    Conclusions: HCWs in COVID-19 patient care in Sweden have been infected with SARS-CoV-2 at a higher rate compared to blood donors. We demonstrate substantial variation between different IgG-assays and propose that multiple serological targets should be used to verify past infection. Our data suggest that CD4
    MeSH term(s) Adult ; Aged ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; CD4-Positive T-Lymphocytes/immunology ; COVID-19/immunology ; Female ; Follow-Up Studies ; Health Personnel ; Humans ; Immunity/immunology ; Immunoglobulin G/immunology ; Male ; Middle Aged ; Pandemics/prevention & control ; SARS-CoV-2/immunology ; Seroepidemiologic Studies ; Sweden ; Young Adult
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; Immunoglobulin G
    Language English
    Publishing date 2021-11-02
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.750448
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top